← SynDRA
VECURONIUM
SynDRA canonical compound SYN0023475 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CHRNA2 |
| Mechanism of action | Acetylcholine receptor antagonist |
| Indication | muscle relaxant |
| Disease area | neurology/psychiatry |
All known targets
- CHRNA2
- CHRM1
- CHRM2
- CHRM3
- CHRM4
- CHRM5
- CHRNA1
- CHRNA4
- CHRNB1
- CHRNB2
- CHRNB4
- CHRND
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRNA2 ANTAGONIST
- CHRNA1 ANTAGONIST
- CHRNB1 ANTAGONIST
- CHRND ANTAGONIST
Drug classes
- Cholinergic Agents
- Cholinergic Antagonists
- Nondepolarizing Neuromuscular Blocker
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Neuromuscular Nondepolarizing Agents
- Neurotransmitter Agents
- Nicotinic Antagonists
- Peripheral Nervous System Agents
ATC classes
- M03A · MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Cross-references
Synonyms
- vecuronium hydrobromide
- vecuronium citrate
- vecuronium maleate
- vecuronium hydrochloride
- vecuronium HCl
- Org NC 45
- vecuronium bromide
- Vecuronium cation
- Vecuronium ion
- Norcuron (TN)
- (2A,3A,5A,16A,17A)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane
- (2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane
- [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
- CHEBI:9939
- RefChem:56988
- DTXCID9024146
- NCGC00167467-01
- UNII-5438723848
- VECURONIUM [VANDF]
- Epitope ID:116647
- VECURONIUM [WHO-DD]
- GTPL4002
- SCHEMBL13575838
- HMS2090D22
- BDBM50424713
- ORG NC 45 / ORG-NC 45
- AKOS025290368
- NCGC00167467-07
- NS00008707
- C07553
- AB00698366-05
- AB00698366-07
- AB00698366_08
- BRD-K20168442-004-06-3
- Norcuron®
- Norcuron
- Vecuroniumbromid
- Vecuronio
Look up VECURONIUM in the interactive SynDRA portal →